These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9058743)

  • 21. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
    Schriber J; Milk B; Shaw D; Christiansen N; Baer M; Slack J; Tezcan H; Wetzler M; Herzig G
    Bone Marrow Transplant; 1999 Dec; 24(12):1311-4. PubMed ID: 10627640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
    Litzow MR; Repoussis PD; Schroeder G; Schembri-Wismayer D; Batts KP; Anderson PM; Arndt CA; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Noël P; Solberg LA; Letendre L; Hoagland HC
    Leuk Lymphoma; 2002 Nov; 43(11):2099-107. PubMed ID: 12533034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
    Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
    Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veno-occlusive disease of the liver after bone marrow transplantation: is hypercoagulability really part of the problem?
    Korte W
    Blood Coagul Fibrinolysis; 1997 Oct; 8(7):367-81. PubMed ID: 9391717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
    Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
    Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
    Carreras E; Bertz H; Arcese W; Vernant JP; Tomás JF; Hagglund H; Bandini G; Esperou H; Russell J; de la Rubia J; Di Girolamo G; Demuynck H; Hartmann O; Clausen J; Ruutu T; Leblond V; Iriondo A; Bosi A; Ben-Bassat I; Koza V; Gratwohl A; Apperley JF
    Blood; 1998 Nov; 92(10):3599-604. PubMed ID: 9808553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation.
    Südhoff T; Heins M; Söhngen D; Lenz V; Wehmeier A; Aul C; Meckenstock G; Schneider W; Reinauer H; Heyll A
    Eur J Haematol; 1998 Feb; 60(2):106-11. PubMed ID: 9508351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased lung uptake of 99Tcm-sulphur colloid as an early indicator of the development of hepatic veno-occlusive disease in bone marrow transplant patients.
    Jacobson AF; Teefey SA; Higano CA; Bianco JA
    Nucl Med Commun; 1993 Aug; 14(8):706-11. PubMed ID: 8371897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation.
    Sartori MT; Cesaro S; Peruzzo M; Messina C; Saggiorato G; Calore E; Pillon M; Varotto S; Spiezia L; Cella G
    Pediatr Blood Cancer; 2012 May; 58(5):791-7. PubMed ID: 21674760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
    El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
    Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation.
    Schuler U; Subat S; Schmidt H; Schneider A; Ehninger G
    Ann Hematol; 1996 Jul; 73(1):25-8. PubMed ID: 8695719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen.
    Salat C; Holler E; Kolb HJ; Hiller E
    Lancet; 1993 Oct; 342(8878):1062. PubMed ID: 8105301
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients.
    Reiss U; Cowan M; McMillan A; Horn B
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):746-50. PubMed ID: 12468917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GI complications in pediatric patients post-BMT.
    Barker CC; Anderson RA; Sauve RS; Butzner JD
    Bone Marrow Transplant; 2005 Jul; 36(1):51-8. PubMed ID: 15908980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen.
    Eltumi M; Trivedi P; Hobbs JR; Portmann B; Cheeseman P; Downie C; Risteli J; Risteli L; Mowat AP
    Lancet; 1993 Aug; 342(8870):518-21. PubMed ID: 8102667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.
    McDonald GB; Hinds MS; Fisher LD; Schoch HG; Wolford JL; Banaji M; Hardin BJ; Shulman HM; Clift RA
    Ann Intern Med; 1993 Feb; 118(4):255-67. PubMed ID: 8420443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.